Identification and Exploration of Serine Peptidase Inhibitor Kazal Type I (SPINK1) as a Potential Biomarker Correlated with the Progression of Non-Small Cell Lung Cancer
-
Published:2022-10-04
Issue:4
Volume:80
Page:807-818
-
ISSN:1085-9195
-
Container-title:Cell Biochemistry and Biophysics
-
language:en
-
Short-container-title:Cell Biochem Biophys
Author:
Li Dingyi, Zhang Xinxin, Ding Zhiqiang, Ai Rongshuang, Shi Luyao, Wang Zimeng, He Qian, Dong Yilin, Zhu Yiting, Ouyang Wenzhong, He YujuanORCID
Funder
Innovative Research Group Project of the National Natural Science Foundation of China Natural Science Foundation Project of CQCSTC
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Biochemistry,General Medicine,Biophysics
Reference35 articles.
1. Jemal, A., Siegel, R., & Ward, E., et al. (2007). Cancer statistics, 2007. CA: A Cancer Journal for Clinicians, 57, 43–66. 2. Zheng, X., Cheng, M., & Fu, B., et al. (2015). Targeting LUNX inhibits non-small cell lung cancer growth and metastasis. Cancer Research, 75, 1080–1090. 3. Molina, J. R., Yang, P., & Cassivi, S. D., et al. (2008). Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clinic Proceedings, 83, 584–594. 4. Herbst, R. S., Heymach, J. V., & Lippman, S. M. (2008). Lung cancer. New England Journal of Medicine, 359, 1367–1380. 5. Lemjabbar-Alaoui, H., Hassan, O. U., & Yang, Y. W., et al. (2015). Lung cancer: Biology and treatment options. Biochim Biophys Acta, 1856, 189–210.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|